cGMP Manufacturing for Regenerative Medicine : Excellos

cGMP Manufacturing for Regenerative Medicine and Advanced Therapies

Excellos runs a fully operational state-of-the art cGMP manufacturing facility for Advanced Therapies, including Regenerative Medicine and Cancer Immunotherapies. Our scientific and cell manipulation expertise is first-class and across the full continuum, taking investigational cellular products and advanced therapies from development to commercialization.

Our cell manufacturing capabilities include the development, scale-up and cGMP clinical production of cells, offering the following services:

Apheresis and cord blood collection
Autologous and allogeneic collections
Production of large cell banks through isolation, genetic modification, separation, and expansion
Viral gene transduction of T cells
CAR-T cell development and expansion
Generation of master cell banks and clinical product lots
Storage and transport

Contact Us to learn more